$TAK

2 theses

bullish 0%neutral 0%bearish 100%

Avg return (3m)

—

Win rate (3m)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$TAKSEC Form 4bearish

Shannon Elaine Mary · Pres., Global Supply & Quality at TAKEDA PHARMACEUTICAL CO LTD · 4h agono track record yet

Sold 20,363 @ $17.55 avg · $357,371 · 2026-08-11

Form 4: Shannon Elaine Mary sold TAK

Shannon Elaine Mary (Pres., Global Supply & Quality at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 20,363 shares of TAK at an average $17.55, roughly $357,371, in a Form 4 filed 2026-08-12.

1d—

3d—

1w—

1m—

3m—

6m—

1y—

View filing on SEC.gov →

$TAKSEC Form 4bearish

Greenway Nicola Deidre Petal · Chief Human Resources Officer at TAKEDA PHARMACEUTICAL CO LTD · 4h agono track record yet

Sold 34,603 @ $17.51 avg · $605,778 · 2026-08-10

Form 4: Greenway Nicola Deidre Petal sold TAK

Greenway Nicola Deidre Petal (Chief Human Resources Officer at TAKEDA PHARMACEUTICAL CO LTD) reported an open-market sale of 34,603 shares of TAK at an average $17.51, roughly $605,778, in a Form 4 filed 2026-08-12.

1d—

3d—

1w—

1m—

3m—

6m—

1y—

View filing on SEC.gov →

End of results.